MacFarlan Smith

MacFarlan Smith is a pharmaceutical company based in Edinburgh, Scotland. It is a subsidiary of Johnson Matthey, a British multinational speciality chemicals and sustainable technologies company. MacFarlan Smith is known for its production of opiates and other controlled substances for use in the pharmaceutical industry.

History

MacFarlan Smith was founded in 1817 by Alexander Smith and George MacFarlan. The company initially focused on the production of medical chemicals and pharmaceuticals. In 2007, it was acquired by Johnson Matthey, expanding its reach and capabilities.

Products and Services

MacFarlan Smith is a leading provider of controlled substances for the global pharmaceutical industry. The company specializes in the production of opiates, including morphine, codeine, and thebaine. It also produces other pharmaceutical ingredients such as gallium, indium, and thallium compounds.

Research and Development

The company is committed to research and development (R&D) in the pharmaceutical sector. It invests in new technologies and processes to improve the production and quality of its products. MacFarlan Smith's R&D efforts also focus on developing new pharmaceutical ingredients and expanding its product portfolio.

Regulatory Compliance

MacFarlan Smith operates under strict regulatory compliance. The company adheres to the regulations set by the Medicines and Healthcare products Regulatory Agency (MHRA) and the United States Food and Drug Administration (FDA). It also complies with the Controlled Substances Act in the production and distribution of controlled substances.

See Also

• Pharmaceutical industry in the United Kingdom
• List of pharmaceutical companies
• Johnson Matthey

External Links

• Official Website